After another solid year that included 12% growth in the top line, Vertex has bumped up its compensation for CEO Reshma Kewalramani, M.D., to $21.5 million, according to the company’s proxy filing.
Reshma Kewalramani’s journey to become the first female CEO of a large, public U.S. biotechnology company after immigrating from India at age 11 embodies what makes America great. In 2018, her ...
Dr. Reshma Kewalramani says she was destined to love science and medicine, raised by parents who always dreamed she would become a doctor and who immigrated to the U.S. from India to give her the best ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback